BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8003286)

  • 1. Oncosuppressor genes: mechanisms of inactivation for the retinoblastoma gene and p53.
    Clerico L; Mancuso T; Noonan D; Albini A
    Boll Soc Ital Biol Sper; 1993 Dec; 69(12):725-34. PubMed ID: 8003286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor genes.
    Levine AJ
    Bioessays; 1990 Feb; 12(2):60-6. PubMed ID: 2140509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
    Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
    Chang F; Syrjänen S; Kurvinen K; Syrjänen K
    Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor suppressor genes and their role in abnormal production of leukocytes (leukemogenesis)].
    Furukawa Y
    Rinsho Ketsueki; 1993 May; 34(5):572-7. PubMed ID: 8315827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and lung cancer.
    Brambilla E; Brambilla C
    Pathol Biol (Paris); 1997 Dec; 45(10):852-63. PubMed ID: 9769949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.
    Wang NP; To H; Lee WH; Lee EY
    Oncogene; 1993 Feb; 8(2):279-88. PubMed ID: 8426737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
    Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARF mutation accelerates pituitary tumor development in Rb+/- mice.
    Tsai KY; MacPherson D; Rubinson DA; Nikitin AY; Bronson R; Mercer KL; Crowley D; Jacks T
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16865-70. PubMed ID: 12486224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens.
    Morgenbesser SD; Williams BO; Jacks T; DePinho RA
    Nature; 1994 Sep; 371(6492):72-4. PubMed ID: 8072529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death.
    Knudsen KE; Weber E; Arden KC; Cavenee WK; Feramisco JR; Knudsen ES
    Oncogene; 1999 Sep; 18(37):5239-45. PubMed ID: 10498874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms for inactivation of tumor suppressor genes].
    Ishizaki K
    Nihon Rinsho; 1995 Nov; 53(11):2660-5. PubMed ID: 8538022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutations of several tumor suppressor genes in primary retinoblastoma].
    Huang Q; Tao Y; Yandell DW
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
    Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
    Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
    de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell cycle, tumor suppressor genes and lung cancers].
    Bréchot JM
    Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular control of the cell cycle in cancer: biological and clinical aspects.
    Møller MB
    Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.